Inventor · disambiguated record
Sanjeev Mariathasan
Also filed as: MARIATHASAN SANJEEV
16 granted patents·27 pending applications·1,391 citations·filing 2009–2025
93Inventor score
Top patents by PatentIndex Score
43 records- 0196US9920123B2Anti-PD-L1 antibodies, compositions and articles of manufactureGENENTECH INC·Filed 2016·Granted Mar 20, 2018·30 cites·30 claims
- 0295US8217149B2Anti-PD-L1 antibodies, compositions and articles of manufactureIRVING BRYAN·Filed 2009·Granted Jul 10, 2012·1.3k cites·61 claims
- 0391US11279767B2Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2018·Granted Mar 22, 2022·7 cites·11 claims
- 0490US8617556B2Gram-positive bacteria specific binding compoundsBEAUMONT TIM·Filed 2011·Granted Dec 31, 2013·12 cites·74 claims
- 0588US9399673B2Gram-positive bacteria specific binding compoundsGENENTECH INC·Filed 2013·Granted Jul 26, 2016·7 cites·17 claims
- 0687US9090677B2Gram-positive bacteria specific binding compoundsGENENTECH INC·Filed 2013·Granted Jul 28, 2015·6 cites·35 claims
- 0786US9803002B2Anti-wall teichoic antibodies and conjugatesGENENTECH INC·Filed 2014·Granted Oct 31, 2017·6 cites·58 claims
- 0885US2023287127A1Anti-pd-l1 antibodies, compositions and articles of manufactureGENENTECH INC·Filed 2023·Application pending·0 cites
- 0984US9458228B2Gram-positive bacteria specific binding compoundsGENENTECH INC·Filed 2015·Granted Oct 4, 2016·3 cites·46 claims
- 1083US11535671B2Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2019·Granted Dec 27, 2022·2 cites·33 claims
- 1182US9266943B2Gram-positive bacteria specific binding compoundsGENENTECH INC·Filed 2013·Granted Feb 23, 2016·3 cites·58 claims
- 1281US2025180562A1Therapeutic and diagnostic methods for bladder cancerGENENTECH INC·Filed 2024·Application pending·0 cites
- 1378US2025382370A1Anti-pd-l1 antibodies, compositions and articles of manufactureGENENTECH INC·Filed 2025·Application pending·0 cites
- 1478US2024190967A1Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2023·Application pending·0 cites
- 1573US2021032345A1Anti-pd-l1 antibodies, compositions and articles of manufactureGENENTECH INC·Filed 2020·Application pending·0 cites
- 1671US12331128B2Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2022·Granted Jun 17, 2025·0 cites·13 claims
- 1771US9884126B2Anti-wall teichoic antibodies and conjugatesGENENTECH INC·Filed 2014·Granted Feb 6, 2018·1 cites·26 claims
- 1868US2021208143A1Therapeutic and diagnostic methods for bladder cancerGENENTECH INC·Filed 2021·Application pending·0 cites
- 1967US2015322153A1Anti-pd-l1 antibodies and articles of manufactureGENENTECH INC·Filed 2014·Application pending·0 cites
- 2067US2019016807A1Anti-pd-l1 antibodies, compositions and articles of manufactureGENENTECH INC·Filed 2018·Application pending·0 cites
- 2166US2018292391A1Gram-positive bacteria specific binding compoundsGENENTECH INC·Filed 2018·Application pending·0 cites
- 2265US2014065135A1Methods of using anti-pd-l1 antibodies and their use to enhance t-cell function to treat tumor immunityGENENTECH INC·Filed 2013·Application pending·0 cites
- 2364US2024141437A1Methods and compositions for neoadjuvant and adjuvant urothelial carcinoma therapyGENENTECH INC·Filed 2023·Application pending·0 cites
- 2464US2023151103A1Stromal gene signatures for diagnosis and use in immunotherapyGENENTECH INC·Filed 2022·Application pending·0 cites
- 2563US9927428B2Gram-positive bacteria specific binding compoundsGENENTECH INC·Filed 2016·Granted Mar 27, 2018·0 cites·66 claims
- 2662US9688745B2Gram-positive bacteria specific binding compoundsGENENTECH INC·Filed 2015·Granted Jun 27, 2017·0 cites·39 claims
- 2762US2013045202A1Anti-pd-l1 antibodies and articles of manufactureGENENTECH INC·Filed 2012·Application pending·0 cites
- 2862US2013045201A1Methods of using anti-pd-l1 antibodies and their use to enhance t-cell function to treat tumor immunityGENENTECH INC·Filed 2012·Application pending·0 cites
- 2962US2013045200A1Methods of using anti-pd-l1 antibodies and their use to treat infection resulting from t-cell dysfunctionGENENTECH INC·Filed 2012·Application pending·0 cites
- 3061US2025257134A1Therapeutic and diagnostic methods for bladder cancerGENENTECH INC·Filed 2025·Application pending·0 cites
- 3160US2016222117A1Nucleic acid encoding anti-pd-l1 antibodiesGENENTECH INC·Filed 2015·Application pending·0 cites
- 3257US10570192B2Anti-wall teichoic antibodies and conjugatesGENENTECH INC·Filed 2017·Granted Feb 25, 2020·0 cites·11 claims
- 3357US2024060135A1Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2022·Application pending·0 cites
- 3456US2011020323A1Gram-positive bacteria specific binding compoundsBEAUMONT TIM·Filed 2010·Application pending·0 cites
- 3553US2018085470A1Anti-wall teichoic antibodies and conjugatesGENENTECH INC·Filed 2017·Application pending·0 cites
- 3653US2019085087A1Stromal gene signatures for diagnosis and use in immunotherapyGENENTECH INC·Filed 2018·Application pending·0 cites
- 3752US2014356375A1Anti-wall teichoic antibodies and conjugatesGENENTECH INC·Filed 2014·Application pending·0 cites
- 3851US9895450B2Anti-wall teichoic antibodies and conjugatesGENENTECH INC·Filed 2015·Granted Feb 20, 2018·0 cites·23 claims
- 3950US2018037655A1Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2017·Application pending·0 cites
- 4048US2021332143A1Combination therapy for cancer comprising pd-1 axis binding antagonist and il6 antagonistGENENTECH INC·Filed 2021·Application pending·0 cites
- 4146US2019309071A1Methods of treating cancer using anti-pd-l1 antibodies and antiandrogensGENENTECH INC·Filed 2019·Application pending·0 cites
- 4245US2018021450A1Anti-staphylococcus aureus antibody rifamycin conjugates and uses thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 4340US2018125995A1Anti-staphylococcus aureus antibody rifamycin conjugates and uses thereofGENENTECH INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sanjeev Mariathasan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →